DOI: 10.1055/s-00000054

Pharmacopsychiatry

Issue 04 · Volume 37 · July 2004 DOI: 10.1055/s-002-3443

Original Paper

Original Paper

147
Deuschle, M.; Kniest, A.; Niemann, H.; Erb-Bies, N.; Colla, M.; Hamann, B.; Heuser, I.: Impaired Declarative Memory in Depressed Patients Is Slow To Recover: Clinical Experience
157
Müller, M. J.; Rossbach, W.; Mann, K.; Röschke, J.; Müller-Siecheneder, F.; Blümler, M.; Wetzel, H.; Ruß, H.; Dittmann, R. W.; Benkert, O.: Subchronic Effects of Olanzapine on Sleep EEG in Schizophrenic Patients with Predominantly Negative Symptoms
163
Bock, Nathalie; Moll, Gunther H.; Wicker, Maike; Pilz, Jürgen; Rüther, Eckart; Banaschewski, Tobias; Huether, Gerald; Rothenberger, Aribert: Early Administration of Tiapride to Young Rats without Long-lasting Changes in the Development of the Dopaminergic System
168
Samborski, W.; Lezanska-Szpera, M.; Rybakowski, J. K.: Open Trial of Mirtazapine in Patients with Fibromyalgia
171
175
Sim, K.; Su, A.; Leong, J. Y.; Yip, K.; Chong, M.-Y.; Fujii, S.; Yang, S.; Ungvari, G. S.; Si, T.; Chung, E. K.; Tsang, H.-Y.; Shinfuku, N.; Kua, E. H.; Tan, C. H.: High Dose Antipsychotic Use in Schizophrenia: Findings of the REAP (Research on East Asia Psychotropic Prescriptions) Study

Letter

189
Bliesener, N.; Yokusoglu, H.; Quednow, B. B.; Klingmüller, D.; Kühn, K.-U.: Usefulness of Bromocriptine in the Treatment of Amisulpride-induced Hyperprolactinemia